By Business/Source
Currency:USD
2024/FY
Stock NameRevenueRatio
Traditional Chinese Medicine Derivatives (TCMD) products sales14.03M60.92%
Third-party products sales9M39.08%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
People’s Republic of China (PRC)23.02M100.00%